Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Area of Science:

• Biomedical science
• Immunology
• Neurology
• Metabolomics
• Microbiomics

Background:

• Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multi-system disorder characterized by profound fatigue and post-exertional malaise.
• The precise molecular underpinnings of ME/CFS remain poorly understood, hindering diagnostic biomarker development.
• Patient heterogeneity in symptoms and triggers complicates research and treatment strategies.

Purpose of the Study:

• To investigate the molecular basis of ME/CFS by integrating findings from various biomedical fields.
• To identify potential diagnostic biomarkers for ME/CFS.
• To understand the complex interplay of physiological disturbances contributing to ME/CFS.

Main Methods:

• Review and synthesis of current research on ME/CFS.
• Analysis of immunological, inflammatory, autonomic, neurological, muscular, mitochondrial, metabolic, and gut-related data.
• Exploration of potential molecular pathologies and homeostatic shifts.

Main Results:

• Evidence points to significant disturbances in immune and inflammatory pathways.
• Neurological and autonomic dysfunction are consistently observed in ME/CFS patients.
• Abnormalities in muscle, mitochondrial function, metabolism, and gut microbiota are implicated.
• A unifying molecular pathology involving a widespread homeostatic shift is hypothesized.

Conclusions:

• ME/CFS has a tangible biomedical basis involving multiple interconnected systems.
• Identifying diagnostic biomarkers is a critical research priority.
• Patient stratification is essential for future diagnostic and therapeutic developments due to disease heterogeneity.